158 related articles for article (PubMed ID: 35947881)
1. Cost-Related Medication Nonadherence and Patient Cost Responsibility for Rural and Urban Cancer Survivors.
Williams CP; Davidoff A; Halpern MT; Mollica M; Castro K; Allaire B; de Moor JS
JCO Oncol Pract; 2022 Aug; 18(8):e1234-e1246. PubMed ID: 35947881
[TBL] [Abstract][Full Text] [Related]
2. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018.
Li M; Bounthavong M
J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087
[No Abstract] [Full Text] [Related]
3. Cost-related medication nonadherence among adolescent and young adult cancer survivors.
Kaul S; Avila JC; Mehta HB; Rodriguez AM; Kuo YF; Kirchhoff AC
Cancer; 2017 Jul; 123(14):2726-2734. PubMed ID: 28542734
[TBL] [Abstract][Full Text] [Related]
4. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors.
Nekhlyudov L; Madden J; Graves AJ; Zhang F; Soumerai SB; Ross-Degnan D
J Cancer Surviv; 2011 Dec; 5(4):395-404. PubMed ID: 21800053
[TBL] [Abstract][Full Text] [Related]
5. Examining urban and rural differences in perceived timeliness of care among cancer patients: A SEER-CAHPS study.
Mollica MA; Weaver KE; McNeel TS; Kent EE
Cancer; 2018 Aug; 124(15):3257-3265. PubMed ID: 29878305
[TBL] [Abstract][Full Text] [Related]
6. Chronic Medication Nonadherence and Potentially Preventable Healthcare Utilization and Spending Among Medicare Patients.
Zhang Y; Flory JH; Bao Y
J Gen Intern Med; 2022 Nov; 37(14):3645-3652. PubMed ID: 35018567
[TBL] [Abstract][Full Text] [Related]
7. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
8. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
[TBL] [Abstract][Full Text] [Related]
9. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
[TBL] [Abstract][Full Text] [Related]
10. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
[TBL] [Abstract][Full Text] [Related]
11. The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries.
Blanchard J; Madden JM; Ross-Degnan D; Gresenz CR; Soumerai SB
Ann Emerg Med; 2013 Nov; 62(5):475-485. PubMed ID: 23726522
[TBL] [Abstract][Full Text] [Related]
12. Prescription drug coverage satisfaction and medication nonadherence among Medicare beneficiaries with cancer.
Silverman C; Ng BP; Baek C; Park C
Expert Rev Pharmacoecon Outcomes Res; 2022 Sep; 22(6):971-979. PubMed ID: 35484941
[TBL] [Abstract][Full Text] [Related]
13. Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression.
Chang CY; Park H; Hincapie-Castillo JM; Heldermon CD; Diaby V; Yang S; Wilson DL; Lo-Ciganic WH
J Manag Care Spec Pharm; 2023 Apr; 29(4):431-445. PubMed ID: 36989452
[No Abstract] [Full Text] [Related]
14. Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States.
Lee MJ; Khan MM; Salloum RG
J Manag Care Spec Pharm; 2018 Jan; 24(1):56-64. PubMed ID: 29290172
[TBL] [Abstract][Full Text] [Related]
15. Cost-Related Medication Nonadherence and Cost-Reduction Strategies Among Elderly Cancer Survivors with Self-Reported Symptoms of Depression.
Gu D; Shen C
Popul Health Manag; 2020 Apr; 23(2):132-139. PubMed ID: 31287770
[TBL] [Abstract][Full Text] [Related]
16. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Frankenfield DL; Howell BL; Wei II; Anderson KK
Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare.
Lu ZK; Xiong X; Brown J; Horras A; Yuan J; Li M
Front Pharmacol; 2021; 12():706289. PubMed ID: 34267667
[No Abstract] [Full Text] [Related]
18. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M
J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of care coordination among older adult cancer survivors: A SEER-CAHPS study.
Mollica MA; Buckenmaier SS; Halpern MT; McNeel TS; Weaver SJ; Doose M; Kent EE
J Geriatr Oncol; 2021 Apr; 12(3):446-452. PubMed ID: 32943359
[TBL] [Abstract][Full Text] [Related]
20. Cost-Related Medication Nonadherence Among Older Adults: Findings From a Nationally Representative Sample.
Chung GC; Marottoli RA; Cooney LM; Rhee TG
J Am Geriatr Soc; 2019 Dec; 67(12):2463-2473. PubMed ID: 31437309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
